XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.40

+0.8%

9:53 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (16432)	11/22/2003 2:04:03 AM
From: Bluegreen	Read Replies (1) of 17367

Hey Bob, how many people with Psoriasis are in the gray zone of MILD to MODERATE???? Where is the line into MODERATE to get Raptiva?????? Won't patients be DEMANDING to be treated???? You have an excellent model when you look how Enbrel started out treating Rheumatoid arthritis..........and OH YEAH don't forget the mantra back then was Insurance wouldn't pay for such an expensive medication!!!!!! THEN WOW!!!!!!!!!!! All of a sudden HUGE demand for Enbrel which led to HUGE shortage!!!!! Will this debate turn into huge number of patients demanding these biologics for Psoriasis just like the model of Enbrel for rheumatoid arthritis??????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next